Polyclonal Antibodies
Anti-Ataxin-3 (ATXN3) Rabbit Polyclonal Antibody for WB, IF/ICC, ELISA - P54252
Item Number : CM0014644
Price varies based on specs and customizations
- Application
- WB, IF/ICC, ELISA
- Cross Reactivity
- Human, Mouse
- Protein Weight
- 41kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | Ataxin-3 (ATXN3) Rabbit pAb |
| Remarks/Alias | AT3; JOS; MJD; ATX3; MJD1; SCA3; Ataxin-3 (ATXN3) |
| Species | Human |
| Gene ID | 4287 |
| Immunogen | Recombinant fusion protein containing a sequence corresponding to amino acids 1-361 of human Ataxin-3 (ATXN3) (NP_004984.2) |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IF/ICC, ELISA |
| Cross Reactivity | Human, Mouse |
| SWISS | P54252 |
| Protein Weight | 41kDa |
| Shipping | Ice bag |
Biological Background: Ataxin-3 Function and Localization
- Ataxin-3 (ATXN3) is a deubiquitinating enzyme that binds long polyubiquitin chains and trims them, with weak activity on short chains (PubMed:17696782). Related references: PMID:17696782
- Ataxin-3 is involved in the degradation of misfolded chaperone substrates via its interaction with STUB1/CHIP, where it restricts ubiquitin chain extension on STUB1/CHIP substrates (By similarity).
- Ataxin-3 acts as a histone-binding protein and represses transcription by interacting with key transcription regulators (PubMed:12297501). Related references: PMID:12297501
- Ataxin-3 negatively regulates mTORC1 signaling in response to amino acid deprivation by deubiquitinating RHEB (PubMed:33157014). Related references: PMID:33157014
- Ataxin-3 regulates autophagy by deubiquitinating BECN1 at Lys-402, leading to BECN1 stabilization (PubMed:28445460). Related references: PMID:28445460
- Ataxin-3 localizes to the nucleus matrix, nucleoplasm, and lysosome membrane.
- Ataxin-3 is ubiquitously expressed across tissues.
- Mutations in ATXN3, characterized by CAG triplet repeat expansions, cause Machado-Joseph disease (spinocerebellar ataxia type 3), a progressive neurodegenerative disorder.
Experimental Guidance and Technical Tips
- The immunogen covers amino acids 1-361 of human Ataxin-3 (NP_004984.2), representing nearly the full-length protein. For optimal results in WB, consider using whole-cell lysates from human or mouse cell lines known to express ATXN3, such as neuronal or muscle cells.
- For IF/ICC, validate the antibody in cells expressing endogenous ATXN3, as subcellular localization may vary (nuclear matrix, nucleoplasm, lysosomes).
- In ELISA applications, use recombinant Ataxin-3 protein as a positive control to establish assay sensitivity.
- Ensure adequate negative controls (e.g., ATXN3 knockout cell lines or siRNA-mediated knockdown) to verify specificity.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio specializes in providing a comprehensive range of IVD raw materials for diagnostic manufacturers, including validated antibody pairs, optimized monoclonal/polyclonal antibodies, and bulk ancillary reagents. Our Ataxin-3 antibody supports research in neurodegeneration, protein quality control, and autophagy, and we assist in sourcing rare target raw materials to accelerate your diagnostic development from concept to clinic.
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!